E. Parlayan Et Al. , "Neurometabolic Correlations of Donepezil and Rivastigmine in Dementia Patients: A Different Neuroprotective Effect," JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , vol.21, no.3, pp.348-350, 2009
Parlayan, E. Et Al. 2009. Neurometabolic Correlations of Donepezil and Rivastigmine in Dementia Patients: A Different Neuroprotective Effect. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , vol.21, no.3 , 348-350.
Parlayan, E., Yulug, B., Bakar, M., & Gumustas, O., (2009). Neurometabolic Correlations of Donepezil and Rivastigmine in Dementia Patients: A Different Neuroprotective Effect. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , vol.21, no.3, 348-350.
Parlayan, Ebru Et Al. "Neurometabolic Correlations of Donepezil and Rivastigmine in Dementia Patients: A Different Neuroprotective Effect," JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , vol.21, no.3, 348-350, 2009
Parlayan, Ebru Et Al. "Neurometabolic Correlations of Donepezil and Rivastigmine in Dementia Patients: A Different Neuroprotective Effect." JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , vol.21, no.3, pp.348-350, 2009
Parlayan, E. Et Al. (2009) . "Neurometabolic Correlations of Donepezil and Rivastigmine in Dementia Patients: A Different Neuroprotective Effect." JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES , vol.21, no.3, pp.348-350.
@article{article, author={Ebru Parlayan Et Al. }, title={Neurometabolic Correlations of Donepezil and Rivastigmine in Dementia Patients: A Different Neuroprotective Effect}, journal={JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES}, year=2009, pages={348-350} }